je.st
news
Home
› Boehringer Ingelheim Announces Agreement with Ceva Sant Animale for Sale of Certain Merial Assets
Boehringer Ingelheim Announces Agreement with Ceva Sant Animale for Sale of Certain Merial Assets
2016-10-14 02:00:00| ThePigSite - Industry News
GLOBAL - Boehringer Ingelheim, Merial and Ceva Santé Animale (Ceva) have announced that Boehringer Ingelheim and Ceva, a leading global animal health company headquartered in Libourne, France, with vaccine manufacturing presence within the European Union, have entered into a binding put option agreement according to which Ceva will purchase certain assets of Merial’s portfolio in the context of Boehringer Ingelheim’s business swap with Sanofi.
Tags: sale
agreement
assets
announces
Category:Agriculture and Forestry